NovolinR (Novo Nordisk)
Welcome to the PulseAid listing for the Novolin drug offered from Novo Nordisk. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novo Nordisk |
NON-PROPRIETARY NAME: | Human Insulin |
SUBSTANCE NAME: | INSULIN HUMAN |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1991-06-25 |
END MARKETING DATE: | 0000-00-00 |
Novolin R HUMAN OTC DRUG Details:
Item Description | Novolin R from Novo Nordisk |
LABELER NAME: | Novo Nordisk |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100([iU]/mL) |
START MARKETING DATE: | 1991-06-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0169-1833_e7ea8689-2a6a-4b6a-8dbe-4b0acca6badc |
PRODUCT NDC: | 0169-1833 |
APPLICATION NUMBER: | NDA019938 |
Other INSULIN HUMAN Pharmaceutical Manufacturers / Labelers: